17/03/2014 - 15:51

Virax takeover clinches anti-cancer drug

17/03/2014 - 15:51

Bookmark

Save articles for future reference.

Virax Holdings has agreed to acquire Pathway Oncology in a reverse takeover which will see the Australia-listed company gain control of a global licence for emerging anti-cancer technology.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options